Clinical Trial Update: ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression. [Phase 4]

View source ↗

Summary

The Phase 4 ESP Study evaluating adding Fuzeon (enfuvirtide) to an antiretroviral regimen in fuzeon-naive patients with sustained HIV suppression has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fuzeon (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 4 | Status: WITHDRAWN